Keerthi Shetty News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Keerthi shetty. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Keerthi Shetty Today - Breaking & Trending Today
Earlier, the nearly three-minute long trailer of Maidaan delved deep into the struggles of the game and showcased Ajay in the role of an inspiring coa ....
World Photography Day is a day which celebrates art, craft, science and history all at once. It was on August 19, 1839, French Academy of Sciences patented the Daguerreo- type process, the method to create a permanent image with a camera. Talking of art and science of photography, we talk to fashion ....
Date Time Personalized vaccine produces long-lasting anti-tumor response in patients with melanoma, study shows Four years after patients with melanoma were treated with a personalized cancer vaccine, the immune response kindled by the vaccine remains robust and effective in keeping cancer cells under control, researchers at Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and the Broad Institute of MIT and Harvard report in a new study. The findings, published online today by the journal Nature Medicine, demonstrate the staying power of the immune response generated by the vaccine, known as NeoVax, which works by targeting specific proteins on each patient’s tumor cells. The researchers found that, nearly four years after vaccination, the patients’ immune system cells were active not only against tumor cells with those distinctive proteins, but also spread to other proteins found in those patients’ tumor cells. ....
E-Mail BOSTON - Four years after patients with melanoma were treated with a personalized cancer vaccine, the immune response kindled by the vaccine remains robust and effective in keeping cancer cells under control, researchers at Dana-Farber Cancer Institute, Brigham and Women s Hospital, and the Broad Institute of MIT and Harvard report in a new study. The findings, published online today by the journal Nature Medicine, demonstrate the staying power of the immune response generated by the vaccine, known as NeoVax, which works by targeting specific proteins on each patient s tumor cells. The researchers found that, nearly four years after vaccination, the patients immune system cells were active not only against tumor cells with those distinctive proteins, but also spread to other proteins found in those patients tumor cells. ....